Gilead Sciences, Inc. (GILD) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
Gilead Sciences, Inc. presented at the RBC Capital Markets Global Healthcare Conference 2026. The Chief Medical Officer, Dietmar Berger, discussed key developments and upcoming data points for their product Trodelvy. The conference provided a platform for Gilead to engage with investors and analysts in the healthcare sector.
- ▪Gilead Sciences, Inc. participated in the RBC Capital Markets Global Healthcare Conference 2026.
- ▪Dietmar Berger, the Chief Medical Officer, represented the company during the presentation.
- ▪The discussion included significant upcoming data points for the drug Trodelvy.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4906570-gilead-sciences-inc-gild-presents-at-rbc-capital-markets-global-healthcare-conference-2026"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
